Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

NCT00085813 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Cancer

Interventions

DRUG: Ispinesib

Sponsor

GlaxoSmithKline